TCMD
Tactile Systems
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
TCMD Profile
Tactile Systems Technology, Inc.
A leader in developing at-home therapies for underserved chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease
Healthcare Equipment and Supplies
01/30/1995
07/28/2016
NASDAQ Stock Exchange
1,037
12-31
Common stock
3701 Wayzata Blvd, Suite 300, Minneapolis, Minnesota 55416
--
Tactile Systems Technology, Inc., was established on January 30, 1995. The company is a medical technology company that develops and sells home physiotherapy devices for the treatment of chronic diseases. They focus on improving the standard of physiotherapy for the treatment of chronic diseases, improving the effectiveness of treatment and quality of life, and helping to control the reduction of health care expenditure. They have a unique and developable platform to provide home therapy programs across the United States. This medical method has been recognized by the government and taxpayers as the key to controlling the rising medical costs in the continuous development. Their initial focus area of treatment is vascular disease, with the aim of raising the standard of home physiotherapy for lymphedema and chronic venous insufficiency. Their main products are two kinds, one is Flexitouch System, which is used for home treatment of lymphedema, and the other is ACTitouch System, which provides physiotherapy equipment worn all day for patients with chronic venous insufficiency.